SevoCOPD: Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients

Sponsor

Employee's State Insurance Corporation, New Delhi (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT06108973

Collaborator

Medtronic Spine LLC (Industry)

Enrollment

14.9

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be studied in accordance with age, sex, duration , type of surgery, site of surgery and BMI.The volume consumption of sevoflurane is compared with Chronic Obstructive Pulmonary Disease and Normal Patients .

Condition or Disease	Intervention/Treatment	Phase
Chronic Obstructive Pulmonary Disease	Device: Capnography

Detailed Description

Chronic Obstructive pulmonary disease is known to escalate the consumption of Inhalation Agents in General Anesthesia. Hence the Data to Collect the Official Record

Study Design

Study Type:

Observational

Anticipated Enrollment :

45 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients Under General Anesthesia

Anticipated Study Start Date :

Jan 1, 2024

Anticipated Primary Completion Date :

Dec 30, 2024

Anticipated Study Completion Date :

Mar 30, 2025

Arms and Interventions

Arm	Intervention/Treatment
Normal Patients Normal patients without any Lung Pathology for General Anesthesia	Device: Capnography To know the Co2 graph in COPD and Normal patients under General Anesthesia
COPD patients Established Chronic Obstructive Pulmonary Disease for General Anesthesia	Device: Capnography To know the Co2 graph in COPD and Normal patients under General Anesthesia

Arm

Intervention/Treatment

Normal Patients

Normal patients without any Lung Pathology for General Anesthesia

Device: Capnography

To know the Co2 graph in COPD and Normal patients under General Anesthesia

COPD patients

Established Chronic Obstructive Pulmonary Disease for General Anesthesia

Device: Capnography

To know the Co2 graph in COPD and Normal patients under General Anesthesia

Outcome Measures

Primary Outcome Measures

Estimation of Volume consumption of Sevoflurane [8 weeks]
The consumption is expressed in Volume ml/kg

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Both Sex All Age Group Patient willing to give consent COPD patient

Exclusion Criteria:

Not willing to give consent Cancerous Lung Lung Lobectomy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Employee's State Insurance Corporation, New Delhi
Medtronic Spine LLC

Investigators

Principal Investigator: Dr Manjunath, MD, ESIC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Santhosh Kumar T N, Nursing Orderly, Employee's State Insurance Corporation, New Delhi

ClinicalTrials.gov Identifier:

NCT06108973

Other Study ID Numbers:

00127102023

First Posted:

Oct 31, 2023

Last Update Posted:

Oct 31, 2023

Last Verified:

Oct 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Yes

Product Manufactured in and Exported from the U.S.:

Yes

Additional relevant MeSH terms:

Lung Diseases

Lung Diseases, Obstructive

Pulmonary Disease, Chronic Obstructive

Study Results

No Results Posted as of Oct 31, 2023